Enabling a traditional Australian medicinal plants agribusiness

Enabling a traditional Australian medicinal plants agribusiness
  • Reference # HT.2.1718007
  • Project Status Completed
  • Timeframe 2 years (2019 to 2021)
  • Project manager N/A
  • CRCNA Funding $363,636
  • Total project value $1,142,032
  • Project research participant Integria Healthcare (Australia) Pty Ltd ; Traditional Homeland Enterprises Holding Co Pty Ltd ; Menzies School of Health Research ; The University of Queensland ;
  • Research Programs 2. New and developing industries in northern Australia
  • Location Menzies School of Health Research, Darwin, Delye Outstation (Daly River, NT),Tiwi Island,Brisbane (Integria Healthcare and The University of Queensland)
  • First Nations led business development
  • Agriculture
  • Health service delivery

Summary

This project established a model for a new agribusiness in northern Australia based on native medicinal plants. It combined science and traditional Indigenous knowledge to develop a prototype range of natural healthcare products, to be marketed nationally and internationally.

The project serves as a model for the collaborative and commercial development of an untapped natural resource, involving Indigenous enterprises, Indigenous rangers, researchers and a leading natural healthcare company with established markets in Australia, Asia, Europe and North America. Raw materials – in the form of medicinal plants – will be sourced from northern Australia and scientifically evaluated at the Menzies School of Health Research in Darwin and The University of Queensland in Brisbane.

Integria Healthcare explored the development and marketing of new topical products using native plant extracts as active ingredients, while Traditional Homeland Enterprises established a sustainable supply chain in northern Australia. Benefit-sharing and intellectual property management were conducted in accordance with best current practices.

Publications

Expected outcomes

  • Within 3 to 5 years, even with modest market penetration in the topical antimicrobial and anti-inflammatory sectors, the project value impact could reach $2 million per annum. Over the longer-term (5 to 10 years), this could grow to $20 million per annum, assuming successful marketing and international uptake.
  • The project supports the development of a local industry with opportunities for Indigenous workforce participation, sustainable regional development in northern Australia, and the potential export of uniquely Australian, value-added products.